Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration‐resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance)
暂无分享，去创建一个
K. Owzar | M. Ratain | P. Friedman | M. Morris | H. McLeod | E. Small | M. Kelley | M. Carducci | J. Patel | S. Halabi | W. Kelly | F. Mulkey | Chen Jiang | D. Hertz | J. Mahoney | Flora Mulkey